AMEX · Healthcare · Biotechnology
CEL-SCI Corporation
CVM
CEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases. CEO Geert R. Kersten · Market cap $14.6M.
$2.13
-0.61 · -22.26%
52w hi $10.6252w lo $0.89
Off 52w high 88.1%
71
NOTABLE
Current InsiderScore
Corp · 90d
1
1 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
5
0 strong · 5 notable
Analyst consensus
Strong Buy
—
Section 01
Recent Form 4 filings
6 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Aug 25 | Geert R Kersten | Chief Executive Officer | Buy | 100,000 | $1.38 | +$138K | 71 |
| May 14 | Geert R Kersten | Chief Executive Officer | Buy | 300,000 | $1.20 | +$360K | 74 |
| May 13 | Geert R Kersten | Chief Executive Officer | Buy | 100,000 | $1.19 | +$119K | 72 |
| Jan 22 | Geert R Kersten | Chief Executive Officer | Buy | 38,023 | $5.26 | +$200K | 69 |
| Dec 04 | Geert R Kersten | Chief Executive Officer | Buy | 8,389 | $5.96 | +$50K | 60 |
| Jul 25 | Geert R Kersten | Chief Executive Officer | Buy | 29,197 | $6.85 | +$200K | 72 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
NovDecJanFebMarAprMayJunJulAugSepOct